Key statistics
On Friday, Corcept Therapeutics Inc (CORT:NAQ) closed at 32.15, 12.18% above the 52 week low of 28.66 set on Feb 19, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 32.77 |
|---|---|
| High | 33.12 |
| Low | 31.81 |
| Bid | 31.85 |
| Offer | 33.00 |
| Previous close | 32.39 |
| Average volume | 1.18m |
|---|---|
| Shares outstanding | 106.37m |
| Free float | 94.25m |
| P/E (TTM) | 38.72 |
| Market cap | 3.42bn USD |
| EPS (TTM) | 0.8303 USD |
Data delayed at least 15 minutes, as of Mar 13 2026 20:00 BST.
More ▼
- Corcept Therapeutics Announces Fourth Quarter and Full-Year 2025 Audited Financial Results, Provides Corporate Update
- Corcept Provides Update on Patent Dispute with Teva Pharmaceuticals
- Corcept Therapeutics to Announce Fourth Quarter and Full-Year 2025 Financial Results, Provide Corporate Update and Host Conference Call
- Overall Survival Primary Endpoint Met in Corcept’s Pivotal Phase 3 ROSELLA Trial of Relacorilant in Patients with Platinum-Resistant Ovarian Cancer
- Corcept Receives Complete Response Letter for Relacorilant as a Treatment for Patients with Hypercortisolism
More ▼
